College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
Theriogenology. 2012 Oct 1;78(6):1303-11. doi: 10.1016/j.theriogenology.2012.05.027. Epub 2012 Aug 13.
The objective was to use dual markers to accurately select genetically modified donor cells and ensure that the resulting somatic cell nuclear transfer kids born were transgenic. Fetal fibroblast cells were transfected with dual marking gene vector (pCNLF-ng) that contained the red-shifted variant of the jellyfish green fluorescent protein (LGFP) and neomycin resistance (Neo) markers. Cell clones that were G418-resistant and polymerase chain reaction-positive were subcultured for several passages; individual cells of the clones were examined with fluorescence microscopy to confirm transgenic integration. Clones in which every cell had bright green fluorescence were used as donor cells for nuclear transfer. In total, 86.7% (26/30) cell clones were confirmed to have transgenic integration of the markers by polymerase chain reaction, 76.7% (23/30) exhibited fluorescence, but only 40% (12/30) of these fluorescent cell clones had fluorescence in all cell populations. Moreover, through several cell passages, only 20% (6/30) of the cell clones exhibited stable LGFP expression. Seven transgenic cloned offspring were produced from these cells by nuclear transfer. Overall, the reconstructed embryo fusion rate was 76.6%, pregnancy rates at 35 and 60 days were 39.1% and 21.7%, respectively, and the offspring birth rate was 1.4%. There were no significant differences between nuclear transfer with dual versus a single (Neo) marker (overall, 73.8% embryo fusion rate, 53.8% and 26.9% pregnancy rates, and 1.9% birth rate with five offspring). In conclusion, the use of LGFP/Neo dual markers and an optimized selection procedure reliably screened genetically modified donor cells, excluded pseudotransgenic cells, and led to production of human lactoferrin transgenic goats. Furthermore, the LGFP/Neo markers had no adverse effects on the efficiency of somatic cell nuclear transfer.
目的是使用双重标记物准确选择基因修饰供体细胞,并确保产生的体细胞核移植后代为转基因动物。将双标记基因载体(pCNLF-ng)转染胎儿成纤维细胞,该载体包含红色荧光水母绿色荧光蛋白(LGFP)的变体和新霉素抗性(Neo)标记物。对 G418 抗性和聚合酶链反应阳性的细胞克隆进行多次传代培养;通过荧光显微镜检查克隆中的单个细胞,以确认转基因整合。每个细胞都具有明亮绿色荧光的克隆被用作核移植的供体细胞。共有 86.7%(26/30)的细胞克隆通过聚合酶链反应证实了标记物的转基因整合,76.7%(23/30)显示荧光,但只有 40%(12/30)的荧光细胞克隆在所有细胞群体中都有荧光。此外,通过多次细胞传代,只有 20%(6/30)的细胞克隆表现出稳定的 LGFP 表达。从这些细胞中通过核移植产生了 7 只转基因克隆后代。总体而言,重构胚胎融合率为 76.6%,35 天和 60 天的妊娠率分别为 39.1%和 21.7%,后代出生率为 1.4%。与单标记(Neo)相比,双标记(LGFP/Neo)的核移植没有显著差异(总体胚胎融合率为 73.8%,妊娠率为 53.8%和 26.9%,出生率为 1.9%,有 5 只后代)。总之,使用 LGFP/Neo 双标记物和优化的选择程序可可靠地筛选基因修饰供体细胞,排除假转基因细胞,并导致人乳铁蛋白转基因山羊的产生。此外,LGFP/Neo 标记物对体细胞核移植的效率没有不良影响。